Rigel Pharmaceutical Inc. buy Citigroup Inc.
Start price
12.11.24
/
50%
€0.74
Target price
12.11.25
€46.15
Performance (%)
-
End price
13.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rigel Pharmaceutical Inc. | - | - | - |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) had its price target raised by analysts at Citigroup Inc. from $40.00 to $49.00. They now have a "buy" rating on the stock.
Ratings data for RIGL provided by MarketBeat
In the thread Trading Rigel Pharmaceutical Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.74
06.03.25
06.03.25
€50.83
06.03.26
06.03.26
-
07.03.26
07.03.26
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.40
07.03.24
07.03.24
€3.67
07.03.25
07.03.25
-47.24%
08.03.25
08.03.25

